title: [Guidelines for gastroenteropancreatic neuroendocrine tumors--what is new? What should be incorporated in daily therapeutic decisions?].
abstract: Neuroendocrine neoplasias are seldom, but increasing. This holds true for the incidence but even more for the prevalence, since patients are able to live with their disease for quite a long time. The European Neuroendocrine Tumor Society (ENETS) as well as other societies (NANETS: North American Neuroendocrine Tumor Society; NCCN: National Comprehensive Cancer Network; ESMO: European Society of Medical Oncology) have published diagnostic and therapeutic guidelines that we present in this review. We aim to summarize those actual guidelines in a practice-based diagnostic and therapeutic algorithm, but also wish to point to open questions that have to be discussed in a multidisciplinary approach.
authors.affiliation: Charité, Gastroenterologie, Berlin, Germany.
authors.forename: P
authors.initials: P
authors.lastname: Grabowski
authors.affiliation: Zentralklinik Bad Berka GmbH, Gastroenterologie, Bad Berka, Germany.
authors.forename: D
authors.initials: D
authors.lastname: Hörsch
mesh_terms: D000465:Algorithms; D000066491:Clinical Decision-Making; D005060:Europe; D005762:Gastroenterology / Q000592:standards*; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis / Q000628:therapy*; D005858:Germany; D006801:Humans; D038622:Internationality; D008495:Medical Oncology / Q000592:standards*; D018358:Neuroendocrine Tumors / Q000175:diagnosis / Q000628:therapy*; D009656:North America; D010190:Pancreatic Neoplasms / Q000175:diagnosis / Q000628:therapy*